OneMedNet (NASDAQ:ONMD) Stock: Insider Aaron Green Sells 5,000 Shares

OneMedNet Corporation (NASDAQ:ONMD) CEO Aaron Green sold 5,000 shares of OneMedNet stock in a transaction on Tuesday, September 22nd. The stock was sold at an average price of $7.39, for a total value of $36,950.00. Following the sale, the chief executive officer directly owned 249,638 shares of the company’s stock, valued at $1,844,824.82. This represents a 1.96% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Aaron Green also recently made the following trade(s):

• On Thursday, September 24th, Aaron Green sold 1,667 shares of OneMedNet stock. The shares were sold at an average price of $6.48, for a total transaction of $10,802.16.

OneMedNet Stock Performance

Shares of NASDAQ:ONMD traded down $0.52 during midday trading on Friday, hitting $4.30. 24,653 shares of the stock were exchanged, compared to its average volume of 69,105. OneMedNet Corporation has a 12 month low of $4.30 and a 12 month high of $42.20. The business’s 50-day moving average price is $6.24 and its 200 day moving average price is $7.32. The stock has a market capitalization of $25.50 million, a price-to-earnings ratio of -2.69 and a beta of 1.14.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded shares of OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat, OneMedNet presently has a consensus rating of “Sell”.

About OneMedNet

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.